Salarius Pharmaceuticals (SLRX) Scheduled to Post Quarterly Earnings on Friday

Salarius Pharmaceuticals (NASDAQ:SLRXGet Rating) will be announcing its earnings results after the market closes on Friday, August 5th. Analysts expect the company to announce earnings of ($0.11) per share for the quarter. Investors interested in registering for the company’s conference call can do so using this link.

Salarius Pharmaceuticals (NASDAQ:SLRXGet Rating) last announced its earnings results on Thursday, May 12th. The company reported ($0.13) EPS for the quarter. On average, analysts expect Salarius Pharmaceuticals to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Salarius Pharmaceuticals Trading Up 8.5 %

Shares of SLRX opened at $0.18 on Thursday. Salarius Pharmaceuticals has a 12 month low of $0.16 and a 12 month high of $1.20. The firm’s 50 day moving average is $0.20 and its 200-day moving average is $0.30. The stock has a market capitalization of $10.35 million, a PE ratio of -0.50 and a beta of 1.13.

About Salarius Pharmaceuticals

(Get Rating)

Salarius Pharmaceuticals, Inc, a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma.

Read More

Earnings History for Salarius Pharmaceuticals (NASDAQ:SLRX)

Want More Great Investing Ideas?

Receive News & Ratings for Salarius Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Salarius Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.